Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: zurdo who wrote (2791)	5/22/1998 10:12:00 PM
From: Paul Tran	Read Replies (1) \| Respond to of 9523

FDA will not close the chapter on these 6 deaths easily. They will drag on and on as they drag on to approve a drug. The NEGATIVE effect on PFE will last very long, and the POSITIVE effect on VVUS will last as long.

To: zurdo who wrote (2791)	5/22/1998 10:14:00 PM
From: Paul Tran	Respond to of 9523

PFE is more diversified and big. So Viagra effect may not bring it down much. But it will create a more positive effect on VVUS. VVUS is a pure player in this erection. VVUS is beaten down, look at the chart. Expecting a more positive release from VVUS Investor Relation. With more bad press coverage on PFE, VVUS will get more attention. VVUS just got South Africa and Sweden approval. VVUS got 50% short interest. FDA will not close the chapter on these 6 deaths soon. It will drag on. As they drag on to approve any drugs.

To: zurdo who wrote (2791)	5/22/1998 10:15:00 PM
From: Paul Tran	Read Replies (2) \| Respond to of 9523

Biotech: Sex and Death. Look at this link: techstocks.com Scary huh ! The choice is yours. Whatever FDA results coming out, it maybe weeks. But in the meantime, the negative drum on Viagra will get covered widely, with so much press coverage on Viagra impotency, now I am expecting about the same amount of coverage on Viagra potential deathly effect. 1. VVUS has been beaten down 2. Lately added Sweden and South Africa. 3. The short volume out there will get squeezed (50% short interest) 4. Plus the negative drum beating on Viagra for the next week.

To: zurdo who wrote (2791)	5/22/1998 10:18:00 PM
From: Paul Tran	Read Replies (2) \| Respond to of 9523

Maybe a hedge on PFE with VVUS, a repost from other thread. Fair value of Vivus is over $20.00/share. The following events should help at least double our share price. 1)FDA approval of new plant--to be announced no later than Monday June first. 2)Increasing script numbers starting week ending May 15. 3)Viagra hype coming to an end. The media hyped it and now they will bash it which is typical of great American journalism. 4)Short interest still ridiculously high. Maybe the shorts will start thinking about covering when we hit 15 and they can then cover us to 20+. 5)A lot of money is leaving big name computer/chip stocks and fund managers are now looking for VALUE. Vivus is VALUE at current prices. 6)Rumors have been hot about Astra or Janssen buying out Vivus. If this is so you can expect at least a 100% gain the day the announcement is made. 7)Over the last year international sales were not a consideration in the stock price but now they should be. Vivus claims that it is shipping out all product it can make. Vivus did not expect as great of a demand as is presently occuring in England. Lower demand in the USA during the Viagra hype has actually been a blessing for Vivus--they are able to ship extra product to Astra for sale in England which would have been in short supply if more MUSE was needed domestically. England will not have a supply shortage which adversely effected MUSE sales in the USA when supply could not meet demand. To those waiting on the sidelines wondering what to do all I can say is jump in on Tuesday while the price is still low. The media exposure this Friday alone has been very good for Vivus. Vivus is getting free media exposure for MUSE as a safe local alternative to the dangers of Viagra. Just watch the news this weekend for more free MUSE press. Maybe Jay Leno will crack a few more MUSE jokes like last time which popped us to $15.00+ in a few trading days.